David Francis

Title: Innovations of David Francis in Nanoparticle Technology

Introduction

David Francis is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of nanoparticle technology, particularly in the development of compositions that utilize vasoactive intestinal peptide antagonists. His work is pivotal in advancing medical applications that leverage these innovative materials.

Latest Patents

David Francis holds a patent for "Nanoparticles conjugated with vasoactive intestinal peptide antagonists." This patent relates to compositions that comprise an antagonist of vasoactive intestinal polypeptide signaling coupled to a nanoparticle. In certain embodiments, the nanoparticle is a poloxamer-stabilized polypropylene sulfide nanoparticle. This innovation has the potential to enhance therapeutic strategies in various medical fields.

Career Highlights

David Francis is affiliated with Emory University, where he continues to engage in groundbreaking research. His work at the university allows him to collaborate with other leading experts in the field, furthering the impact of his inventions. With a total of 1 patent, he has established himself as a notable figure in nanoparticle research.

Collaborations

David has worked alongside esteemed colleagues such as Edmund K Waller and Susan Thomas. Their collaborative efforts contribute to the advancement of research and innovation in their respective fields.

Conclusion

David Francis exemplifies the spirit of innovation through his work in nanoparticle technology. His contributions are paving the way for new medical applications that could significantly improve patient outcomes.